Real-world data on the effectiveness and safety of teriflunomide in patients with relapsing–remitting multiple sclerosis: The EFFECT study
| Autor: | Durán Herrera, Mª.C., Sánchez, M.D., Aguera, E., Muñoz, C., Alonso, A., Arnal, C., Dotor, J., Barrero, J., Gómez, M., Caballero-Villarraso, J., Hernández, L.L., Cancho, E., Romera, M., Gavilán, T., Castellanos, F., Espinosa, R., Forero, L., Querol-Pascual, R., Roa-Montero, A.M., de Colosía Rama, V.P., Plata, A.G., Parrado, F.P. |
|---|---|
| Zdroj: | In Neurology Perspectives July-September 2022 2(3):134-142 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|